First State Orthopaedics PA Revenue and Competitors

Brookside, DE USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • First State Orthopaedics PA's estimated annual revenue is currently $65M per year.(i)
  • First State Orthopaedics PA's estimated revenue per employee is $297,000

Employee Data

  • First State Orthopaedics PA has 219 Employees.(i)
  • First State Orthopaedics PA grew their employee count by 6% last year.

First State Orthopaedics PA's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.3M340%N/AN/A
#2
$106.7M31623%N/AN/A
#3
$4.7M25N/AN/AN/A
#4
$112.7M33419%N/AN/A
#5
$49M1653%N/AN/A
#6
$0.7M5-37%N/AN/A
#7
$28.1M10417%N/AN/A
#8
$2.8M17-32%N/AN/A
#9
$4M2111%N/AN/A
#10
$1049.3M27769%N/AN/A
Add Company

What Is First State Orthopaedics PA?

We are proud of the fact that many of us have been with First State Orthopaedics for more than 20 years. The physicians at First State Orthopaedics have become an integral part of the community in which we live. By devoting our energy and our time to many charitable causes, we have provided important assistance to those in the community who benefit most from our involvement. Sixteen of us are trained in orthopaedic surgery; two are trained in pain management/rehabilitation and one in non-operative sports medicine. We provide both surgical and nonsurgical treatment for orthopaedic illnesses and injuries, and are specially trained in the current state-of-the-art techniques

keywords:N/A

N/A

Total Funding

219

Number of Employees

$65M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

First State Orthopaedics PA News

2022-04-06 - Comparison of reference distributions acquired by direct and ...

The PRINCE study, as the first national initiative to develop pediatric ... of pediatric reference intervals from Abbott to Beckman, Ortho,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$76.2M2398%N/A
#2
$39.4M2548%N/A
#3
$138M409N/AN/A
#4
$264.8M15764%N/A
#5
$2210M30102%$125M